Rituximab: Lymphoma & Arthritis drugs list & guide

Rituximab is the world's first monoclonal antibody approved for cancer treatment. It specifically targets the CD20 transmembrane antigen found on the surface of B-lymphocytes, triggering cell destruction (lysis).

It remains the "gold standard" for treating B-cell lymphomas and severe autoimmune diseases. On Unifarm, you will find a list of medications (both the original MabThera and high-quality biosimilars) containing this active substance.

Wikipedia page
Rituximab

Indications

  • Non-Hodgkin’s Lymphoma (NHL): Stage III-IV follicular lymphoma, diffuse large B-cell lymphoma (in combination with CHOP chemotherapy).
  • Chronic Lymphocytic Leukemia (CLL): For previously untreated patients or relapsed/refractory cases.
  • Rheumatoid Arthritis (RA): Severe active disease where other DMARDs have failed.
  • Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA).
  • Pemphigus Vulgaris.

Dosage and administration

Administered exclusively via intravenous infusion (slow drip) in a hospital setting equipped with resuscitation facilities.

Key Rules:

  • Premedication: Administration of antihistamines and antipyretics (paracetamol) is mandatory 30–60 minutes before each infusion to reduce the risk of allergic reactions.
  • Regimens (Typical): For lymphoma, the standard dose is 375 mg/m² body surface area. For Rheumatoid Arthritis, a fixed dose of 1000 mg is used (two infusions separated by 2 weeks).
  • Hypersensitivity to rituximab or murine (mouse) proteins.
  • Active, severe infections (e.g., tuberculosis, sepsis).
  • Severe heart failure (specifically for Rheumatoid Arthritis patients).
  • Pregnancy and breastfeeding (risk of B-cell depletion in the fetus).

Infusion-related reactions are the most critical, especially during the first administration:

  • Infusion Reactions: Fever, chills, hives, dyspnea, hypotension (observed in >50% of patients during the first dose).
  • Infections: Hepatitis B virus reactivation (screening is required before starting therapy), increased susceptibility to bacterial infections.
  • Cardiac: Angina pectoris, arrhythmias.
  • Hematologic: Neutropenia, leukopenia.

List of medicines by active substance Rituximab

-10%
Maball 500 500 mg / 50 ml Hetero
View
Hetero

Maball 500

500 mg / 50 ml 1 vial
7695₴ 8574₴
-15%
Reditux 500 500 mg Dr. Reddy's
View
Dr. Reddy's

Reditux 500

500 mg 1 vial
7475₴ 8794₴
-12%
Reditux 100 100 mg Dr. Reddy's
View
Dr. Reddy's

Reditux 100

100 mg 1 vial
4837₴ 5496₴
✅ All products loaded (3)

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00